Nguyen Tran

9PUBLICATIONS

60CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 10, 2026

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Jun 01, 2026

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|Nov 20, 2025

Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo Clinic.

Oudai Sahwan, Fares Jamal, Rish Pai

|Dec 14, 2024

Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience.

Paulina Marell, Ioannis Kournoutas, Jennifer Gile

|Jan 18, 2024

Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer.

Oluwadunni E Emiloju, Michael Storandt, Tyler Zemla

|Nov 11, 2022

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma.

Michael H Storandt, Jennifer J Gile, Mathias E Palmer

Pageof 2

Frequent Collaborators

Mitesh J Borad

Amit Mahipal

Zhaohui Jin

Tanios S Bekaii-Saab

Robert R McWilliams

Fang-Shu Ou

Jennifer J Gile

Aminah Jatoi

Grant Wintheiser

Qian Shi

Frequent Collaborators

Mitesh J Borad

Amit Mahipal

Zhaohui Jin

Tanios S Bekaii-Saab